✦ LIBER ✦

Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes

✍ Scribed by Yan-Ling He; Jessica Valencia; Yiming Zhang; Sherwyn L. Schwartz; Monica Ligueros-Saylan; James Foley; William P. Dole

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucose-lowering activity of the dipepti

✍ J. Rosenstock; S. Sankoh; J. F. List 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Efficacy and safety of the dipeptidyl pe

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB

Long-term safety, tolerability, and effi

✍ Masato Odawara; Takashi Kadowaki; Naoko Tajima; Mikio Nishii; Tadaaki Taniguchi; 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 377 KB

Efficacy and safety of the dipeptidyl pe

✍ R. E. Pratley; M. S. Kipnes; P. R. Fleck; C. Wilson; Q. Mekki; Alogliptin Study 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Efficacy and safety of the dipeptidyl pe

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Effect of adding sitagliptin, a dipeptid

✍ R. Brazg; L. Xu; C. Dalla Man; C. Cobelli; K. Thomas; P. P. Stein 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB